Michael Dudkiewicz, MD
Vascular Surgery · New York, NYNPI 1629221338
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 23.8%. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 847 payments — averaging $110.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$22K
- Acera Surgical, Inc.$19K
- Cook Medical LLC$7K
- Argon Medical Devices, Inc.$6K
- Inari Medical, Inc.$5K
- Shockwave Medical, Inc$5K
- plus $28K from 36 others
Across 10 payments — averaging $5406.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- TEI Medical Inc.$17K
- Integra Lifesciences Corporation$16K
- Kerecis Limited$13K
- Acera Surgical, Inc.$9K
What the payments were for
- Consulting fees$24,23826%
- Speaking & faculty fees$9,58410%
- Travel & lodging$7,3428%
- Food & beverage$50,71154%
- Education$1,6542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Restrata Wound Matrix$18,897
- LUTONIX$5,781
- CT THROMBECTOMY SYSTEM KIT$4,920
- Clot Management$4,582
- FLOWTRIEVER CATHETER, S$3,731
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,642
- Fibrinet$3,101
- INTEGRA$2,639
- COVERA$1,801
- Indigo System$1,708
- Zenith Spiral-Z$1,669
- Torus Stent Graft System$1,539
- ENDOCROSS Device$1,539
- Diamondback Peripheral$1,292
- Zilver PTX$1,132
- INTERLOCK$1,024
- ENROUTE Transcarotid Neuroprotection System$1,011
- 2CM PERIPHERAL CUTTING BALLOON$923
- INTEGRA DERMAL REGENERATION TEMPLATE$880
- PRIMATRIX$880
How this compares
$93,529 in reported general payments places this provider in the 90th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 14 | $169 |
| ClopidogrelClopidogrel Bisulfate | 16 | $135 |
| Triamcinolone Acetonide | 12 | $57 |
| Oxycodone Hcl | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in New York
- Gary GelbfishNew York$1.9M
- John LantisNew York$922K
- Brian DerubertisNew York$714K
- James McKinseyNew York$616K
- Peter FariesNew York$494K
- Ajit RaoNew York$294K
- Daniel HanNew York$280K
- Todd BerlandNew York$260K
- Thomas MaldonadoNew York$249K
- Karan GargNew York$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.